Medicamen Biotech fundamental analysis

MEDICAMEQ

271

4.20 (-1.53%)
Last updated on 13 Mar, 2026 | 15:29 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Medicamen Biotech Fundamentals

P/E Ratio

39.47

P/B Ratio

1.38

Div. Yield

0.36

Sector P/E

59.54

Sector P/B

2.65

Sec. Div. Yield

0.59

Medicamen Biotech Fundamentals is currently trading with a P/E Ratio of 39.47, compared to the sector average of 59.54. Its P/B Ratio stands at 1.38, while the sector’s is 2.65. In terms of returns, the stock offers a Dividend Yield of 0.36%, which is than the sector’s 0.59%.

Medicamen Biotech Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Average

On its scorecard, Medicamen Biotech reflects: Price – Attractive, Growth – Poor, Quality – Poor, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost